GlassScriptPhysician profile
Edgard Nunez
NPI 1477586204
$1,565.44
in general payments reported to CMS, 2019-2025
14 companies · $160 in 2025
The $160 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $396 · 2020: $183 · 2021: $443 · 2022: $44.72 · 2023: $339 · 2025: $160.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $499.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $499.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $335.90 | 2019-2023 | Arexvy |
| E.R. Squibb & Sons, L.L.C. | $233.81 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $207.17 | 2019-2023 | Farxiga |
| Janssen Pharmaceuticals, INC | $185.08 | 2019-2021 | |
| Janssen Biotech, INC. | $138.84 | 2022-2023 | Symtuza |
| Abbott Laboratories | $135.08 | 2025 | Freestyle Libre 3 |
| Abbvie INC. | $112.65 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $105.69 | 2021 | |
| Corcept Therapeutics | $25.20 | 2025 | Korlym |
| Mylan Specialty L.P. | $23.26 | 2020 | |
| Viiv Healthcare Company | $18.74 | 2019 | |
| Radius Health, INC. | $16.50 | 2020 | |
| Pfizer INC. | $13.89 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.63 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edgard Nunez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.